The Trump administration has ended a subsidy program that helped reduce costs for Medicare drug coverage. The move could result in higher monthly expenses for millions of seniors enrolled in the program.
The decision appears to work against the administration's message on drug affordability. President Trump frequently promotes his push for access to cheaper drugs through the TrumpRx platform and making most-favored-nation deals with other countries.